(NewsDirect)
ChitogenX CEO Phil Deschamps joinedProactive's Natalie Stoberman with news of the company'slatest federal grant and partnership deal with Polytechnique Montréalto expand the ORTHO- R platform in regenerative medicine.
Deschamps said the company has obtained a $3,472,000 grant fromThe Natural Sciences and Engineering Research Council of Canada(NSERC) and Prima Québec and will collaborate with PolytechniqueMontréal throughout the four-year grant period to advance thescientific development, expand the scope of indications, develop newbiomaterials for regenerative medicine and accelerate the commercialreadiness of its flagship ORTHO-R technology platform.
ContactDetails
Proactive Canada
+1 604-688-8158
na-editorial@proactiveinvestors.com
Copyright (c) 2023 TheNewswire - All rights reserved.